一个疗程2万4，割肉啊。
As a result, we made the decision to launch a generic version of our leading HCV medications in January 2019. These generics will be marketed by a subsidiary and will have a list price of $24,000 for the most common course of treatment
As a result, we made the decision to launch a generic version of our leading HCV medications in January 2019. These generics will be marketed by a subsidiary and will have a list price of $24,000 for the most common course of treatment